
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Council removes proposal to rename park named after former president of Israel
Favored Vehicle for Seniors: Make Your Determination
Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
The Specialty of Compromise: Examples from Reality
Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth
Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
Which Film Has the Incomparable Melodic Score?
Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed












